[HTML] sciencedirect.com

[HTML][HTML] Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda

N Fukuda, SI Tachibana, M Ikeda… - Parasitology …, 2021 - Elsevier
In Uganda, artemether-lumefantrine was introduced as an artemisinin-based combination
therapy (ACT) for malaria in 2006. We have previously reported a moderate decrease in ex …
被引用次数：12 相关文章

[引用][C] Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda

N Fukuda, SI Tachibana, M Ikeda… - Parasitology …, 2021 - cir.nii.ac.jp
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …

Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda.

N Fukuda, SI Tachibana, M Ikeda… - Parasitology …, 2020 - europepmc.org
In Uganda, artemether-lumefantrine was introduced as an artemisinin-based combination
therapy (ACT) for malaria in 2006. We have previously reported a moderate decrease in ex …

Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda

N Fukuda, SI Tachibana, M Ikeda… - Parasitology …, 2021 - pubmed.ncbi.nlm.nih.gov
In Uganda, artemether-lumefantrine was introduced as an artemisinin-based combination
therapy (ACT) for malaria in 2006. We have previously reported a moderate decrease in ex …

Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in northern Uganda.

N Fukuda, SI Tachibana, M Ikeda… - 2021 - cabidigitallibrary.org
In Uganda, artemether-lumefantrine was introduced as an artemisinin-based combination
therapy (ACT) for malaria in 2006. We have previously reported a moderate decrease in ex …

[引用][C] Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda

N Fukuda, SI Tachibana, M Ikeda… - 2021